NasdaqOn RegSHO · 9 days in a row
$0.0393▼ 3.68%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.3MShares out 32.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 3d agoAfter-hours26.10.22 06:006-KKey event#●●●
China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals terminated the over-allotment option of up to $12 million granted to investors in connection with its October 8 registered direct offering, effective October 21. As a result, investors no longer have the right to purchase additional shares or warrants, though this termination does not affect the securities already issued in the offering.…more
$0.0393-3.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 06:00SCHEDULE 13GOwnership
China SXT Pharmaceuticals, Inc.
Orca Capital AG has filed a Schedule 13G, disclosing its beneficial ownership of more than 5% of China SXT Pharmaceuticals, Inc. This filing formalizes the investor's stake in the company.…more
$0.0393-3.68%vs prev closeView filingShare - 10.9After-hours26.10.10 06:006-KKey event
China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals entered into a securities purchase agreement on October 8, 2026, for a registered direct offering of 8,000,000 units. Each unit consists of one share (or pre-funded warrant) and one ordinary warrant, with aggregate gross proceeds expected to be approximately $12,000,000. The offering closed on October 9, 2026.…more
$0.0393-3.68%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.22 21:09Bullish#●●●
China SXT Pharmaceuticals Announces 1-for-100 Reverse Stock Split
China SXT Pharmaceuticals will implement a 1-for-100 reverse stock split effective October 26, 2026. The company will continue trading on the Nasdaq under the same ticker symbol following the consolidation.…more
$0.0393-3.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 4d agoPre-market26.10.21 21:05
●●●●●●●● ●●●●● ●●●●●●
China SXT Pharmaceuticals announced the termination of a $12 million additional purchase right related to its registered direct offering. This decision marks a change in the company's capital raising strategy.…more
$0.0393-3.68%vs prev closeShareBenzinga - 10.8Pre-market26.10.08 22:26
●●●●●●●● ●●●●● ●●●●●●
China SXT Pharmaceuticals has entered into an agreement to raise approximately $12 million through a registered direct offering of 8 million shares. This issuance of new shares may lead to shareholder dilution.…more
$0.0393-3.68%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report